The site for substance abuse prevention and mental health promotion professionals and volunteers.

Home » Announcements


Watch this page for announcements from other Athena Forum users. Select Send me Announcements in the account settings menu to get notified when there are new postings to this page.

September 16, 2019

The University of Washington and Seattle Children’s Hospital will implement a two-year pilot of school staff mental health education, and telephone and televideo psychiatric consultations for students at middle, junior and high schools in in two Washington school districts. Pilot duration will be during the 2019-20 and 2020-21 school years.

Purpose: To provide (1) professional learning opportunities for school staff and (2) telehealth consultations that serve as one strategy among the school’s multi-tiered system of supports (MTSS)
for behavioral and mental health.

Eligibility: School Districts of 2,000 – 20,000 students that can demonstrate readiness of middle and high schools to:

  1. Identify a lead contact for coordinating services;
  2. Co-develop a professional learning plan with project staff on school mental health using tele-consultation;
  3. Host telemedicine appointments during the school day.

Number of districts to be chosen: 2 - one district east and one west of the Cascades.

See attached letter for more information.

September 16, 2019

The American Foundation for Suicide Prevention (AFSP) and its partners have released Model School District Policy on Suicide Prevention: Model Language, Commentary, and Resources. The document outlines model policies and best practices for school districts to prevent student suicide.

September 11, 2019

The Washington State Liquor and Cannabis Board (LCB) launched rulemaking last fall to revise penalty rules, but the legislative debate during the 2019 Legislative session on ESSB 5318 re-focused the direction and goals of the rule revisions. The agency convened a workgroup of cannabis industry attorneys and other licensees and representatives to collaboratively overhaul the penalty rules. One or two meetings per month were held over several months to re-write the rules. Those work sessions were very productive, collaborative and effective and constitute a model for good governance and best practices in developing regulations.

While these draft conceptual rules represent LCB’s commitment to collaborative rule development and stakeholder engagement, they also accomplish the following:

  • Reduces all fines by 50%;
  • Significantly reducing the number of violations that could result in license cancellation, while balancing penalties across license types;
  • Shifts focus to a compliance and education-based approach designed to encourage and support licensee success;
  • Provides a penalty deferral option;
  • Completely restructures existing penalty grids by establishing penalty categories based on penalty severity and relationship to public health and safety;
  • Reincorporates and associates statutory and regulatory references with violation type;
  • Incorporates mandates of ESSB 5318, including but not limited to establishing a notice of correction, and laying the foundation for the voluntary compliance program; and

LCB welcomes your feedback. They are working on increasing the ways that you can join the conversation and get involved in the rule development process. One of those ways is a rules webpage that will serve as a one-stop resource for all LCB rulemaking activity. While that webpage is being constructed, here are ways you can get involved:

  • Provide comment on this draft conceptual rule set at;
  • Mark your calendar for a September 26 Listen and Learn forum facilitated by Kathy Hoffman, Cannabis Policy and Rules Coordinator (details to follow in early September)
  • Join us at LCB Board meetings and LCB caucus meetings.
September 9, 2019

The Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), state and local health departments, and other clinical and public health partners are investigating a multistate outbreak of severe pulmonary disease associated with e-cigarette product (devices, liquids, refill pods, and/or cartridges) use. This investigation is ongoing and has not identified a cause, but all reported cases have a history of using e-cigarette products.

E-cigarettes are devices that deliver an aerosol to the user by heating a liquid that usually contains nicotine, flavorings, and other chemicals. E-cigarettes can also be used to deliver marijuana or other substances.

While this investigation is ongoing, consider not using e-cigarette products.

If you do use e-cigarette products and you experience symptoms like those reported in this outbreak, seek medical care promptly. CDC and the FDA will continue to alert the public throughout this investigation.

Regardless of the ongoing investigation:

  • Youth and young adults should not use e-cigarette products.
  • Women who are pregnant should not use e-cigarette products.
  • Adults who do not currently use tobacco products should not start using e-cigarette products.
  • If you do use e-cigarette products, you should not buy these products off the street (for example, e-cigarette products with THC or other cannabinoids).
  • You should not modify e-cigarette products or add any substances to these products that are not intended by the manufacturer.
  • Adult smokers who are attempting to quit should use evidence-based treatments, including counseling and FDA-approved medications. If you need help quitting tobacco products, including e-cigarettes, contact your doctor or other medical provider.

If you are concerned about your health after using an e-cigarette product, you can also call your local poison control center at 1-800-222-1222.

CDC and FDA encourage the public to submit detailed reports of any unexpected health or product issues related to tobacco or e-cigarette products to the FDA via the online Safety Reporting Portal.

Read the Investigation Notice for more information.

September 6, 2019

The CADCA Boot Camp is required for new CPWI Coordinators. Please make sure you register by September 15th!

September 6, 2019

The entry period for the 2019 Red Ribbon Photo Contest is October 1st through November 1st.

For more information visit:

September 6, 2019

As part of the Drug Enforcement Administration’s (DEA) Red Ribbon Week campaign, the DEA and the Substance Abuse and Mental Health Services Administration (SAMHSA) are co-sponsoring this Campus Video PSA Contest for colleges and universities to promote the importance of preventing alcohol abuse and the non-medical use of prescription stimulants among college students. Eligible entrants create and submit a 30- to 60-second video PSA showcasing the underlying message behind Red Ribbon Week—commitment to a healthy, drug-free lifestyle, especially among college students.

After drug traffickers murdered DEA Special Agent Enrique “Kiki” Camarena in 1985, Red Ribbon Week has since become an annual event demonstrating intolerance for drugs in our nation’s schools, workplaces, and communities. Each year from October 23–31, people across the United States show their commitment to a healthy, drug-free lifestyle by wearing or displaying the Red Ribbon.

For more information visit:

September 4, 2019

Calling all Prevention and Public Health partners:

It's time to share your voice and expertise! We want to hear your thoughts on possible updates to the Marijuana Packaging and Labeling rules. This will be a focus group type discussion with some presentation from Kathy Hoffman, LCB's Cannabis Policy and Rules Coordinator.

LCB Prevention Focus Group: Marijuana Packaging and Labeling Rules

Tuesday, September 17

12.30-1p: Registration and networking | 1-3p Focus group discussion

Tukwila Community Center | 12424 42nd Ave S Tukwila, WA  98168

RSVP by 9/13 here

Please come prepared to offer specific insights and recommendations for this set of rules. Materials will be sent out in advance for your review.

For further information, contact Sara Cooley Broschart at or 360.522.0421.

We look forward to learning with you!



Note: This is a closed meeting for prevention and public health partners only. Feel free to forward this invitation but keep in mind that criteria.



August 29, 2019

Today, Surgeon General Vice Adm. Jerome M. Adams, issued an advisory emphasizing the importance of protecting youth and pregnant women from the health risks of marijuana use.

Marijuana, or cannabis, is the most commonly used illicit drug in the United States. Delta-9-tetrahydrocannabinol (THC), a component of marijuana, binds to receptors in the brain, producing euphoria and a variety of potentially harmful effects, including intoxication and memory and motor impairments. Newer strains of marijuana have also shown to be increasingly more potent, leading to other risks like anxiety, agitation, paranoia and psychosis. Continue reading here.

August 28, 2019

September is National Suicide Prevention Month, Sept. 8-14 is National Suicide Prevention Week, and Sept. 10 is World Suicide Prevention Day. National suicide prevention partners will be using #BeThere to track our messaging efforts this year. Here are other ways to get involved.